Evidence map›Paper›PMID 30353267›Full record

Trial reportRheumatology international2018

The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin.

Javier Rivera, María José Tercero, Javier Salas Salas, Julio Hernández Gimeno, Javier Sánchez Alejo

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03425903 (Clinical Research, Randomized, Open, Unmasked, Controlled, Cross-group, Active-treatment, to Evaluate the Clinical Efficacy of Whole Body Cryotherapy), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03425903 nacompletednot on this map

Clinical Research, Randomized, Open, Unmasked, Controlled, Cross-group, Active-treatment, to Evaluate the Clinical Efficacy of Whole Body Cryotherapy (WBC) in the Cryosense TCT Cabin for the Treatment of Fibromyalgia

TypeinterventionalSponsorTecnología e Innovación Médico Estética S.L.Ran2016 to 2017Enrolled60ConditionsFibromyalgiaArmsWhole body cryotherapy sessions
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. SIMFER guidelines on physical modalities for chronic primary pain management.European journal of physical and rehabilitation medicine · 2026
    Guideline
  2. Trial
  3. Review
  4. Article
  5. [Whole-body cryotherapy for low back pain].Orthopadie (Heidelberg, Germany) · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Innate immunity changes in soccer players after whole-body cryotherapy.BMC sports science, medicine & rehabilitation · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Javier RiveraReumatología, Instituto Provincial de Rehabilitación, Francisco Silvela 40, 28028, Madrid, Spain. javierrivera@ser.es.
María José TerceroTecnología e Innovación Médico-Estética, S.L., Madrid, Spain.
Javier Salas SalasPoliclínica Meprysa, Madrid, Spain.
Julio Hernández GimenoPoliclínica Meprysa, Madrid, Spain.
Javier Sánchez AlejoTecnología e Innovación Médico-Estética, S.L., Madrid, Spain.
Policlínica Gipuzkoa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence of symptomatic treatment for fibromyalgia (FM) is very low. Whole body cryotherapy (WBC) modulates different neurotransmitters, which might have a role in pain alleviation and could exert an effect on FM. Our aim was to evaluate the efficacy of WBC for the control of pain and impact of disease in FM. For this we run an open, randomized, crossover trial of Cryosense TCT™ cabin vs rest. Patients with FM according to ACR criteria were recruited consecutively from general practices. Trial endpoints were change (∆) in pain after 2 and 4 weeks, measured by a visual analogue scale (VAS), ∆ burden of disease, evaluated by the Fibromyalgia Impact Questionnaire (FIQ), and severity of FM, measured by the Combined Index of Severity of Fibromyalgia (ICAF). Within group differences, sequence and period effects were tested with Student's t or Mann-Whitney U tests. Multiple linear regression models were used to adjust effect by baseline differences between groups. Sixty patients were included in the trial. A period effect was noted, with residual effect of WBC; therefore, only results from the first sequence were analysed. ∆VAS pain, ∆FIQ and ∆ICAF scores were significantly larger in the WBC group after the first period (3.0 vs 0.3 in ∆VAS pain; 32.1 vs 0.4 in ∆FIQ; 13.7 vs 0.07 in ∆ICAF; all p < 0.001), and were confirmed after adjustment. In conclusion, WBC with a Cryosense TCT cabin may be a useful adjuvant therapy for FM; further studies on long-term effect and compared to other physical therapies are warranted.Trial registration NCT03425903.

Indexed as

AdultAgedAged, 80 and overCross-Over StudiesCryotherapyEquipment DesignFemaleFibromyalgiaHumansMaleMiddle AgedPain ManagementPain MeasurementSeverity of Illness IndexSpainSurveys and QuestionnairesClinical trialCold therapyFibromyalgia

Identifiers

PMID30353267
PMCPMC6223856
OpenAlexW2897726815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.